Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

77 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share as of Q3 2021.
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 25.1M shares of 266M outstanding shares and own 9.42% of the company stock.
Largest 10 shareholders include FRAZIER MANAGEMENT LLC (3.53M shares), Capital World Investors (2.96M shares), Nantahala Capital Management, LLC (2.94M shares), Polygon Management Ltd. (2.5M shares), CITADEL ADVISORS LLC (2.4M shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1.67M shares), FMR LLC (1.5M shares), Pendal Group Ltd (1.41M shares), JPMORGAN CHASE & CO (1.35M shares), and Alphabet Inc. (698K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.